Prot #SGN35-IST-049/NU 20H02: Phase II Study of Brentuximab Vedotin in Combination with Pembrolizumab in Patients with Recurrent Systemic Peripheral T-Cell Lymphoma (PTCL)

Project: Research project

Project Details

StatusActive
Effective start/end date2/25/212/25/24

Funding

  • Seattle Genetics, Inc. (Prot #SGN35-IST-049/NU 20H02)